The Business Development Boston Conference, a forum and networking opportunity for pharmaceutical and biotech business development leaders, is returning for its second year. The powerhouse list of hosts includes top executives of RA Capital, Genzyme, Endo Pharmaceuticals, Pfizer, Hoffmann-La Roche, GlaxoSmithKline, Infinity Pharmaceuticals, Vertex, Sirtris Pharmaceuticals, and Biogen Idec.
Individual panels are dedicated to Pharma, VC/Investor, and Biotech. Keynoting is Edmund P. Harrigan, SVP, Worldwide Business Development, for Pfizer.
Update, April 4 — This event is now sold out.